The aforementioned findings suggest that combining RT with a CSF1R inhibitor has shown effectiveness in impeding tumor growth in murine models of Lewis lung carcinoma, CMT167 lung carcinoma, and SCC7 head and neck squamous cell carcinoma in subcutaneous transplant tumor models. This evidence concerns the gene CSF1R and neoplasm.